Bayer and J&J Win Third Xarelto Case

22:38 EDT 21 Aug 2017 | CHEManager

Germany’s Bayer and Johnson & Johnson (J&J) of the US have won the third of three lawsuits involving bleeding risks of the blockbuster blood thinner Xarelto, which was developed and produced by Bayer and is sold in the US by J&J. In the latest case, a jury in the US District Court in Jackson, Mississippi, ruled in favor of the drugmakers against a woman who claimed she developed acute gastrointestinal bleeding after she took Xarelto following an operation in 2015.

Original Article: Bayer and J&J Win Third Xarelto Case


More From BioPortfolio on "Bayer and J&J Win Third Xarelto Case"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...